GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic.

It is important and feasible to pre-determine many of the statistical aspects of an efficient trial design in advance of a disease outbreak. The design can then be tailored to the specific disease under study once its nature is better understood.